Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Noradrenergic modulation of overnight resolution of emotional distress during sleep
NL-OMON56727Completed
- Sponsor
- Netherlands Institute for Neuroscience
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of atomoxetine, nebivolol, daridorexant, clonidine and Placebo-COD Research Private Ltd in anxiety disorder and Insomnia (5 arms), sponsored by Netherlands Institute for Neuroscience. Primary endpoint: Overnight resolution of recent emotional distress. Started Dec 2024; status: completed.
02
Drugs
atomoxetinenebivololdaridorexantclonidinePlacebo-COD Research Private Ltd
03
Conditions
anxiety disorderInsomnia
Beyond the preview
Go deeper on NL-OMON56727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON56727.